Vickie L Capps - Net Worth and Insider Trading
Vickie L Capps Net Worth
The estimated net worth of Vickie L Capps is at least $613,065 dollars as of 2024-11-13. Vickie L Capps is the Director of Silverback Therapeutics Inc and owns about 61,576 shares of Silverback Therapeutics Inc (SBTX) stock worth over $361,451. Vickie L Capps is the Director of Amedisys Inc and owns about 1,780 shares of Amedisys Inc (AMED) stock worth over $161,980. Vickie L Capps is also the Director of NuVasive Inc and owns about 2,000 shares of NuVasive Inc (NUVA) stock worth over $79,500. Besides these, Vickie L Capps also holds Connecture Inc (CNXR) , Otonomy Inc (OTIC) . Details can be seen in Vickie L Capps's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Vickie L Capps has not made any transactions after 2022-11-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Vickie L Capps
Vickie L Capps Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Vickie L Capps owns 8 companies in total, including Otonomy Inc (OTIC) , Amedisys Inc (AMED) , and NuVasive Inc (NUVA) among others .
Click here to see the complete history of Vickie L Capps’s form 4 insider trades.
Insider Ownership Summary of Vickie L Capps
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
OTIC | Otonomy Inc | 2022-11-28 | director |
AMED | Amedisys Inc | 2021-06-08 | director |
NUVA | NuVasive Inc | 2020-11-09 | director |
2020-01-23 | director | ||
2018-04-25 | director | ||
2020-12-08 | director | ||
2021-06-10 | director | ||
2020-12-03 | director |
Vickie L Capps Latest Holdings Summary
Vickie L Capps currently owns a total of 5 stocks. Among these stocks, Vickie L Capps owns 61,576 shares of Silverback Therapeutics Inc (SBTX) as of December 8, 2020, with a value of $361,451 and a weighting of 58.96%. Vickie L Capps owns 1,780 shares of Amedisys Inc (AMED) as of February 25, 2020, with a value of $161,980 and a weighting of 26.42%. Vickie L Capps also owns 2,000 shares of NuVasive Inc (NUVA) as of November 9, 2020, with a value of $79,500 and a weighting of 12.97%. The other 2 stocks Connecture Inc (CNXR) , Otonomy Inc (OTIC) have a combined weighting of 1.65% among all his current holdings.
Latest Holdings of Vickie L Capps
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SBTX | Silverback Therapeutics Inc | 2020-12-08 | 61,576 | 5.87 | 361,451 |
AMED | Amedisys Inc | 2020-02-25 | 1,780 | 91.00 | 161,980 |
NUVA | NuVasive Inc | 2020-11-09 | 2,000 | 39.75 | 79,500 |
CNXR | Connecture Inc | 2016-06-10 | 29,250 | 0.35 | 10,091 |
OTIC | Otonomy Inc | 2022-11-28 | 5,000 | 0.01 | 43 |
Holding Weightings of Vickie L Capps
Vickie L Capps Form 4 Trading Tracker
According to the SEC Form 4 filings, Vickie L Capps has made a total of 1 transactions in Silverback Therapeutics Inc (SBTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Silverback Therapeutics Inc is the acquisition of 9,523 shares on December 8, 2020, which cost Vickie L Capps around $199,983.
According to the SEC Form 4 filings, Vickie L Capps has made a total of 1 transactions in Amedisys Inc (AMED) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Amedisys Inc is the acquisition of 1,000 shares on February 25, 2020, which cost Vickie L Capps around $187,000.
According to the SEC Form 4 filings, Vickie L Capps has made a total of 1 transactions in NuVasive Inc (NUVA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in NuVasive Inc is the acquisition of 2,000 shares on November 9, 2020, which cost Vickie L Capps around $96,460.
More details on Vickie L Capps's insider transactions can be found in the Insider Trading History of Vickie L Capps table.Insider Trading History of Vickie L Capps
- 1
Vickie L Capps Trading Performance
GuruFocus tracks the stock performance after each of Vickie L Capps's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Vickie L Capps is 13.14%. GuruFocus also compares Vickie L Capps's trading performance to market benchmark return within the same time period. The performance of stocks bought by Vickie L Capps within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Vickie L Capps's insider trading performs compared to the benchmark.
Performance of Vickie L Capps
Vickie L Capps Ownership Network
Ownership Network List of Vickie L Capps
Ownership Network Relation of Vickie L Capps
Vickie L Capps Owned Company Details
What does Otonomy Inc do?
Who are the key executives at Otonomy Inc?
Vickie L Capps is the director of Otonomy Inc. Other key executives at Otonomy Inc include Chief Scientific Officer Alan Charles Foster , director & President & CEO David Allen Weber , and CFO/Ch. Business Offcr & Sec. Paul E Cayer .
Otonomy Inc (OTIC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Otonomy Inc (OTIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Otonomy Inc (OTIC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Otonomy Inc (OTIC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Otonomy Inc Insider Transactions
Vickie L Capps Mailing Address
Above is the net worth, insider trading, and ownership report for Vickie L Capps. You might contact Vickie L Capps via mailing address: 2985 Scott Street, Vista Ca 92083.